Island Pharmaceuticals
Island Pharmaceuticals is focused on drug repurposing and clinical development for viral diseases lacking existing therapies. Their business model centers around identifying and developing solutions for unmet medical needs in the treatment of viral infections. The company aims to create value by advancing repurposed drug candidates through clinical trials and ultimately to market.
Short position
Island Pharmaceuticals (ASX:ILA) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 4 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.19% in March 2023. ILA is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Island Pharmaceuticals (ILA) company profile
Profile, insiders and operations
Company
AI-generated research profile of Island Pharmaceuticals
ILA intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links